ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.00%
US Dollar vs MXN
20.37748
-0.25%
Brent Oil
74.64
-0.17%
Bitcoin
98,057.46
0.01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Otonomy Inc (OTIC)

  7. Otonomy Inc (OTIC) Noticias

OTIC

Otonomy (OTIC)

Otonomy Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:OTIC
FechaHoraFuenteTítuloSímboloCompañía
04/04/202314:41Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:OTICOtonomy Inc
03/04/202305:19Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OTICOtonomy Inc
30/03/202315:32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OTICOtonomy Inc
30/03/202315:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OTICOtonomy Inc
30/03/202315:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
24/02/202315:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OTICOtonomy Inc
14/02/202315:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
13/02/202315:57Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OTICOtonomy Inc
30/01/202305:38Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OTICOtonomy Inc
30/12/202215:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
29/12/202208:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OTICOtonomy Inc
27/12/202216:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OTICOtonomy Inc
22/12/202206:53GlobeNewswire Inc.Otonomy Announces Change in Stock Exchange ListingNASDAQ:OTICOtonomy Inc
19/12/202216:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OTICOtonomy Inc
19/12/202215:53GlobeNewswire Inc.Otonomy Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
10/11/202215:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OTICOtonomy Inc
10/11/202215:05GlobeNewswire Inc.Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
13/10/202206:30GlobeNewswire Inc.Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing LossNASDAQ:OTICOtonomy Inc
02/08/202215:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OTICOtonomy Inc
02/08/202205:16TipRanksAnalyst Explains Why They Downgraded Their Rating on Otonomy (OTIC)NASDAQ:OTICOtonomy Inc
01/08/202206:30GlobeNewswire Inc.Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with TinnitusNASDAQ:OTICOtonomy Inc
25/07/202215:05GlobeNewswire Inc.Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
18/07/202206:30GlobeNewswire Inc.Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate UpdateNASDAQ:OTICOtonomy Inc
18/05/202206:30GlobeNewswire Inc.Otonomy to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:OTICOtonomy Inc
12/05/202206:30GlobeNewswire Inc.Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual MeetingNASDAQ:OTICOtonomy Inc
09/05/202215:04GlobeNewswire Inc.Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
02/05/202206:30GlobeNewswire Inc.Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate UpdateNASDAQ:OTICOtonomy Inc
25/04/202205:15TipRanksAnalysts Offer Insights on Healthcare Companies: Amryt Pharma (AMYT) and Otonomy (OTIC)NASDAQ:OTICOtonomy Inc
20/04/202206:30GlobeNewswire Inc.Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing LossNASDAQ:OTICOtonomy Inc
15/03/202206:30GlobeNewswire Inc.Otonomy to Host Virtual Investor R&D Event on March 22, 2022NASDAQ:OTICOtonomy Inc
 Showing the most relevant articles for your search:NASDAQ:OTIC

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
NYSE
CVX
Chevron
CCOM
US30
US 30
USI
USTECH100
US Tech 100
USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
COIN
ADAUSD
Cardano
NYSE
BAC
Bank of America
SPI
SP500
S&P 500
NASDAQ
GOOGL
Alphabet
AMEX
XLV
Health Care Select Sector
NYSE
VZ
Verizon Communications
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados